Recommendations from the AML molecular MRD expert advisory board
Stuart Scott1,2, Alison Devonshire3, Richard Dillon4,5
1UK NEQAS for Leucocyte Immunophenotyping, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. stuart.scott@ukneqasli.co.uk.
Leukemia
|May 23, 2024
Summary
No abstract available in PubMed .


